These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34054913)

  • 21. A polymorphism of the ORAI1 gene is associated with the risk and recurrence of calcium nephrolithiasis.
    Chou YH; Juo SH; Chiu YC; Liu ME; Chen WC; Chang CC; Chang WP; Chang JG; Chang WC
    J Urol; 2011 May; 185(5):1742-6. PubMed ID: 21420116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variation in calcium-sensing receptor and risk for colon cancer.
    Dong LM; Ulrich CM; Hsu L; Duggan DJ; Benitez DS; White E; Slattery ML; Caan BJ; Potter JD; Peters U
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2755-65. PubMed ID: 18843020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms of CASR gene increase the risk of primary hyperparathyroidism.
    Wang XM; Wu YW; Li ZJ; Zhao XH; Lv SM; Wang XH
    J Endocrinol Invest; 2016 Jun; 39(6):617-25. PubMed ID: 26710757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of vitamin D receptor gene Taq I polymorphism with recurrent urolithiasis in children.
    Seyhan S; Yavascaoglu I; Kilicarslan H; Dogan HS; Kordan Y
    Int J Urol; 2007 Dec; 14(12):1060-2. PubMed ID: 18036039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteopontin promoter polymorphisms and risk of urolithiasis: a candidate gene association and meta-analysis study.
    Amar A; Afzal A; Hameed A; Ahmad M; Khan AR; Najma H; Abid A; Khaliq S
    BMC Med Genet; 2020 Aug; 21(1):172. PubMed ID: 32842990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium-sensing receptor gene polymorphisms in patients with calcium urolithiasis: a systematic review.
    Besiroglu H; Sahin S; Otunctemur A; Ozbek E
    Ren Fail; 2014 Sep; 36(8):1187-92. PubMed ID: 25019182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of vitamin D receptor (Fok-I) polymorphism with the clinical presentation of calcium urolithiasis.
    Liu CC; Huang CH; Wu WJ; Huang SP; Chou YH; Li CC; Chai CY; Wu MT
    BJU Int; 2007 Jun; 99(6):1534-8. PubMed ID: 17419705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of TRPV5 gene polymorphism with calcium urolithiasis: a case-control study from West Bengal, India.
    Mitra P; Pal DK; Das M
    World J Urol; 2020 May; 38(5):1311-1322. PubMed ID: 31428848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D receptor gene polymorphisms in children with kidney stone disease.
    Subaşı B; Gökçe İ; Delil K; Alpay H
    Turk J Pediatr; 2017; 59(4):404-409. PubMed ID: 29624220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of vitamin D receptor gene polymorphisms and risk of urolithiasis: results of a genetic epidemiology study and comprehensive meta-analysis.
    Amar A; Afzal A; Hussain SA; Hameed A; Khan AR; Shakoor M; Abid A; Khaliq S
    Urolithiasis; 2020 Oct; 48(5):385-401. PubMed ID: 31515573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D receptor gene polymorphisms in patients with urolithiasis.
    Gunes S; Bilen CY; Kara N; Asci R; Bagci H; Yilmaz AF
    Urol Res; 2006 Feb; 34(1):47-52. PubMed ID: 16397775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients.
    Jeong S; Kim IW; Oh KH; Han N; Joo KW; Kim HJ; Oh JM
    Drug Des Devel Ther; 2016; 10():2211-25. PubMed ID: 27468225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etiologic risk factors and vitamin D receptor gene polymorphisms in under one-year-old infants with urolithiasis.
    Ergon EY; Akil İO; Taneli F; Oran A; Ozyurt BC
    Urolithiasis; 2018 Aug; 46(4):349-356. PubMed ID: 29085969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D receptor and calcium-sensing receptor gene polymorphisms in hypercalciuric stone-forming patients.
    Ferreira LG; Pereira AC; Heilberg IP
    Nephron Clin Pract; 2010; 114(2):c135-44. PubMed ID: 19887834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of vitamin D receptor gene polymorphisms in Turkish infants with urolithiasis.
    Goknar N; Öktem F; Torun E; Gok O; Demir AD; Kucukkoc M; Kilic U
    Ren Fail; 2016; 38(4):545-51. PubMed ID: 26908058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics and calcium nephrolithiasis.
    Vezzoli G; Terranegra A; Arcidiacono T; Soldati L
    Kidney Int; 2011 Sep; 80(6):587-93. PubMed ID: 20962745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OPN gene polymorphism (Ala250) and lower serum OPN levels are associated with urolithiasis.
    Tugcu V; Simsek A; Tarhan T; Atalar F; Bitkin A; Tasci AI; Kural AR; Altug T
    Ren Fail; 2013 Jul; 35(6):825-9. PubMed ID: 23692545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium-sensing receptor: evidence and hypothesis for its role in nephrolithiasis.
    Vezzoli G; Macrina L; Magni G; Arcidiacono T
    Urolithiasis; 2019 Feb; 47(1):23-33. PubMed ID: 30446806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-1beta gene and receptor antagonist gene polymorphisms in patients with calcium oxalate stones.
    Chen WC; Wu HC; Chen HY; Wu MC; Hsu CD; Tsai FJ
    Urol Res; 2001 Oct; 29(5):321-4. PubMed ID: 11762793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of interleukin-18 gene polymorphisms with calcium oxalate kidney stone disease.
    Lai KC; Lin WY; Man KM; Tsai CH; Chen HY; Tsai FJ; Chen FJ; Chen HY; Liu HP; Ho TJ; Huang PH; Liu PL; Lin FY; Shen JL; Liu JT; Chen YH; Chen WC
    Scand J Urol Nephrol; 2010 Feb; 44(1):20-6. PubMed ID: 20017708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.